Rationale and design of Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events III (TRACE III): a randomised, phase III, open-label, controlled trial.
Yun-Yun XiongBruce C V CampbellMarc FisherLee H SchwammMark ParsonsHao LiYue-Song PanXia MengXing-Quan ZhaoYong-Jun WangPublished in: Stroke and vascular neurology (2023)
NCT05141305.
Keyphrases
- open label
- phase iii
- phase ii
- clinical trial
- phase ii study
- study protocol
- liver failure
- double blind
- respiratory failure
- acute myocardial infarction
- cerebral ischemia
- heavy metals
- placebo controlled
- randomized controlled trial
- acute ischemic stroke
- aortic dissection
- subarachnoid hemorrhage
- mesenchymal stem cells
- heart failure
- squamous cell carcinoma
- hepatitis b virus
- brain injury